Esophageal Cancer Surgery Has Lasting Effects on QoL

This article originally appeared here.
Share this content:
Esophageal Cancer Surgery Has Lasting Effects on QoL
Esophageal Cancer Surgery Has Lasting Effects on QoL

(HealthDay News) – Long-term survivors of esophageal cancer surgery who experience postoperative complications continue to experience long-lasting adverse effects on their health-related quality of life (HRQL), according to a study published online April 2 in the Journal of Clinical Oncology.

To assess the impact of postoperative complications on HRQL, Maryam Derogar, of the Karolinska Institutet in Stockholm, and colleagues utilized data from the Swedish Esophageal and Cardia Cancer register to identify 153 patients who had survived for at least five years following esophageal cancer surgery. HRQL was assessed using validated questionnaires.

The researchers found that 141 patients completed the five-year HRQL survey. Of these, 33% sustained a major postoperative complication, which was associated with significantly worse scores for dyspnea, fatigue, and eating restrictions compared with those who did not sustain a major postoperative complication. Sleep difficulties and gastroesophageal reflux worsened during follow-up, while the number of patients with a postoperative complication who had problems with choking decreased.

"In this population-based prospective study of five-year survivors of esophageal cancer surgery, the occurrence of major postoperative complications was found to be an independent predictor for several parameters of poor HRQL," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs